Growth Metrics

Innoviva (INVA) Current Leases (2019 - 2026)

Innoviva posted quarterly Current Leases of $646000.0 for Q1 2026, down 49.53% year-on-year from $1.3 million in Q1 2025, and up 54.55% on a QoQ basis from $418000.0 in Q4 2025.

Innoviva (INVA) has 5 years of Current Leases data on file, last reported at $646000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Leases fell 49.53% year-over-year to $646000.0; the trailing twelve-month figure through Mar 2026 stood at $646000.0 (down 49.53% YoY), and the FY2025 full-year result was $418000.0, down 73.41% from the prior year.
  • Current Leases for Q1 2026 stood at $646000.0, up from $418000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $1.6 million in Q4 2024 and bottomed at $418000.0 in Q4 2025.
  • The 4-year median for Current Leases is $1.1 million (2023), against an average of $1.0 million.
  • The widest annual swing landed in 2024, when Current Leases soared 30.24%; it then tumbled 73.41% in 2025.
  • A 4-year view of Current Leases shows it stood at $1.2 million in 2023, then jumped by 30.24% to $1.6 million in 2024, then sank by 73.41% to $418000.0 in 2025, then soared by 54.55% to $646000.0 in 2026.
  • The last three Current Leases figures came in at $646000.0 (Q1 2026), $418000.0 (Q4 2025), and $680000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 83,991.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 7.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 720.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 45.66 Mn
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn 646,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 646,000.00
Dec 31, 2025 418,000.00
Sep 30, 2025 680,000.00
Jun 30, 2025 983,000.00
Mar 31, 2025 1.28 Mn
Dec 31, 2024 1.57 Mn
Sep 30, 2024 1.51 Mn
Dec 31, 2023 1.21 Mn
Jun 30, 2019 317,000.00
Mar 31, 2019 308,000.00